                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
      PETERLIN, BORIS
 
<120> INHIBITORS OF P-TEFB MEDIATED TRANSCRIPTION

<130> UCSF069PCT

<140>
<141>

<150> 62/739,425
<151> 2018-10-01

<160> 12    

<170> PatentIn version 3.5

<210> 1
<211> 28
<212> PRT
<213> Homo sapiens

<400> 1
Lys Lys Lys His Arg Arg Arg Pro Ser Lys Lys Lys Arg His Trp Lys 
1               5                   10                  15      


Pro Tyr Tyr Lys Leu Thr Trp Glu Glu Lys Lys Lys 
            20                  25              


<210> 2
<211> 9
<212> PRT
<213> Human immunodeficiency virus 1

<400> 2
Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210> 3
<211> 33
<212> PRT
<213> Homo sapiens

<400> 3
Arg Ile Arg Ala Glu Met Phe Ala Lys Gly Gln Pro Val Ala Pro Tyr 
1               5                   10                  15      


Asn Thr Thr Gln Phe Leu Met Asp Asp His Asp Gln Glu Glu Pro Asp 
            20                  25                  30          


Leu 
    


<210> 4
<211> 48
<212> PRT
<213> Human immunodeficiency virus 1

<400> 4
Met Glu Pro Val Asp Pro Tyr Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Arg Thr Ala Cys Asn Asn Cys Tyr Cys Lys Lys Cys Cys Phe 
            20                  25                  30          


His Cys Tyr Ala Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


<210> 5
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gly Gly Gly Gly Ser 
1               5   


<210> 6
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Lys Lys Lys His Arg Arg Arg Pro Ser Lys Lys Lys Arg His Trp Lys 
1               5                   10                  15      


Pro Tyr Tyr Lys Leu Thr Trp Glu Glu Lys Lys Lys Phe Asp Glu Lys 
            20                  25                  30          


Gln Ser Leu Arg Ala Ser Arg Ile Arg Ala Glu Met Phe Ala Lys Gly 
        35                  40                  45              


Gln Pro Val Ala Pro Tyr Asn Thr Thr Gln Phe Leu Met Asp Asp His 
    50                  55                  60                  


Asp Gln Glu Glu Pro Asp Leu Val Asp Met Glu Pro Val Asp Pro Tyr 
65                  70                  75                  80  


Leu Glu Pro Trp Lys His Pro Gly Ser Gln Pro Arg Thr Ala Cys Asn 
                85                  90                  95      


Asn Cys Tyr Cys Lys Lys Cys Cys Phe His Cys Tyr Ala Cys Phe Thr 
            100                 105                 110         


Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
        115                 120     


<210> 7
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
Met Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Arg Lys Lys Arg Arg 
1               5                   10                  15      


Gln Arg Arg Arg Ala Pro Pro Gly Gly Gly Gly Ser Arg Ile Arg Ala 
            20                  25                  30          


Glu Met Phe Ala Lys Gly Gln Pro Val Ala Pro Tyr Asn Thr Thr Gln 
        35                  40                  45              


Phe Leu Met Asp Asp His Asp Gln Glu Glu Pro Asp Leu Val Asp Met 
    50                  55                  60                  


Glu Pro Val Asp Pro Tyr Leu Glu Pro Trp Lys His Pro Gly Ser Gln 
65                  70                  75                  80  


Pro Arg Thr Ala Cys Asn Asn Cys Tyr Cys Lys Lys Cys Cys Phe His 
                85                  90                  95      


Cys Tyr Ala Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
            100                 105                 110     


<210> 8
<211> 93
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
Phe Asp Glu Lys Gln Ser Leu Arg Ala Ser Arg Ile Arg Ala Glu Met 
1               5                   10                  15      


Phe Ala Lys Gly Gln Pro Val Ala Pro Tyr Asn Thr Thr Gln Phe Leu 
            20                  25                  30          


Met Asp Asp His Asp Gln Glu Glu Pro Asp Leu Val Asp Met Glu Pro 
        35                  40                  45              


Val Asp Pro Tyr Leu Glu Pro Trp Lys His Pro Gly Ser Gln Pro Arg 
    50                  55                  60                  


Thr Ala Cys Asn Asn Cys Tyr Cys Lys Lys Cys Cys Phe His Cys Tyr 
65                  70                  75                  80  


Ala Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
                85                  90              


<210> 9
<211> 78
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 9
Lys Lys Lys His Arg Arg Arg Pro Ser Lys Lys Lys Arg His Trp Lys 
1               5                   10                  15      


Pro Tyr Tyr Lys Leu Thr Trp Glu Glu Lys Lys Lys Val Asp Met Glu 
            20                  25                  30          


Pro Val Asp Pro Tyr Leu Glu Pro Trp Lys His Pro Gly Ser Gln Pro 
        35                  40                  45              


Arg Thr Ala Cys Asn Asn Cys Tyr Cys Lys Lys Cys Cys Phe His Cys 
    50                  55                  60                  


Tyr Ala Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly 
65                  70                  75              


<210> 10
<211> 372
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 10
atggaattca agaaaaaaca taggagacgc ccgtccaaga agaagcggca ttggaaaccg       60

tactacaagc tgacctggga agagaagaaa aagttcgacg agaaacagag ccttcgagct      120

tcaaggatcc gagccgagat gttcgccaag ggccagccgg tcgcgcccta taacaccacg      180

cagttcctca tggatgatca cgaccaggag gagccggatc tcgtcgacat ggagccagta      240

gatccatatc tagagccctg gaagcatcca ggaagtcagc ctaggactgc ttgtaacaat      300

tgctattgta aaaagtgttg ctttcattgc tacgcgtgtt tcacaagaaa aggcttaggc      360

atctcctatg gc                                                          372


<210> 11
<211> 279
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 11
ttcgacgaga aacagagcct tcgagcttca aggatccgag ccgagatgtt cgccaagggc       60

cagccggtcg cgccctataa caccacgcag ttcctcatgg atgatcacga ccaggaggag      120

ccggatctcg tcgacatgga gccagtagat ccatatctag agccctggaa gcatccagga      180

agtcagccta ggactgcttg taacaattgc tattgtaaaa agtgttgctt tcattgctac      240

gcgtgtttca caagaaaagg cttaggcatc tcctatggc                             279


<210> 12
<211> 303
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 12
aggaagaagc ggagacagcg acgaagagct cctcctggtg gaggaggctc taggatccga       60

gccgagatgt tcgccaaggg ccagccggtc gcgccctata acaccacgca gttcctcatg      120

gatgatcacg accaggagga gccggatctc gtcgacatgg agccagtaga tccatatcta      180

gagccctgga agcatccagg aagtcagcct aggactgctt gtaacaattg ctattgtaaa      240

aagtgttgct ttcattgcta cgcgtgtttc acaagaaaag gcttaggcat ctcctatggc      300

tag                                                                    303


